Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Pierfranco Conte

51-100 of 275 results

View this query on the Wikidata Query Service
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

scientific article published in August 2006
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

scientific article published on 01 December 2018
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Inst

scientific article published on June 2004
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance.

scientific article published on October 2013
The sequential use of endocrine treatment for advanced breast cancer: where are we?

scientific article
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

scientific article published on 01 April 2019
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors

scientific article published on 01 August 2000
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy

scientific article published on 30 November 2005
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.

scientific article
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.

scientific article
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis

scientific article published on 01 March 2015
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas

scientific article
Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature.

scientific article
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

scientific article
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.

scientific article published on January 2007
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential

scientific article published on 01 January 2013
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.

scientific article
Effects of sulfonylureas on tumor growth: a review of the literature

scientific article published on 16 September 2013
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.

scientific article
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, [...]

scientific article
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).

scientific article
Incidence and Clinical Impact of Sterilized Disease and Minimal Residual Disease After Preoperative Radiochemotherapy for Rectal Cancer

scientific article published on 01 October 2005
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

scientific article
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

scientific article published on 02 November 2013
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

scientific article published on 01 April 1991
Surgical margins in head and neck squamous cell carcinoma: what is ‘close’?

scientific article published on December 28, 2012
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

scientific article published on 22 August 2015
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

scientific article published on May 2002
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on July 2015
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

scientific article
Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies

scientific article published on August 1, 2013
Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.

scientific article published in February 2002
Targeting bone metastatic cancer: Role of the mTOR pathway

scientific article published on 05 February 2014
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

scientific article
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.

scientific article published on January 2015
Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer

scientific article published on 19 May 2011
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

scientific article published on 19 September 2017
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*

scientific article published on July 1, 2001
Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel

scientific article published on 01 November 1996
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

scientific article published on April 2006
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria

scientific article published on 23 September 2006
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.

scientific article published on 7 May 2013
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens

scientific article
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

scientific article published on 30 January 2008
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

scientific article published on 01 June 2019
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

scientific article published on 24 February 2012
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look

scientific article published on 01 September 1990
Whole exome sequencing of rare aggressive breast cancer histologies.

scientific article
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

scientific article published in April 2008
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers

scientific article published on 01 October 1998

Paulina is supported by:

About Paulina

Help